1. Home
  2. LEE vs NXL Comparison

LEE vs NXL Comparison

Compare LEE & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • NXL
  • Stock Information
  • Founded
  • LEE 1890
  • NXL 2010
  • Country
  • LEE United States
  • NXL United States
  • Employees
  • LEE N/A
  • NXL N/A
  • Industry
  • LEE Newspapers/Magazines
  • NXL Medical Specialities
  • Sector
  • LEE Consumer Discretionary
  • NXL Health Care
  • Exchange
  • LEE Nasdaq
  • NXL Nasdaq
  • Market Cap
  • LEE 33.8M
  • NXL 28.0M
  • IPO Year
  • LEE N/A
  • NXL 2022
  • Fundamental
  • Price
  • LEE $4.23
  • NXL $1.50
  • Analyst Decision
  • LEE
  • NXL Strong Buy
  • Analyst Count
  • LEE 0
  • NXL 1
  • Target Price
  • LEE N/A
  • NXL $5.00
  • AVG Volume (30 Days)
  • LEE 33.0K
  • NXL 10.6M
  • Earning Date
  • LEE 12-11-2025
  • NXL 11-07-2025
  • Dividend Yield
  • LEE N/A
  • NXL N/A
  • EPS Growth
  • LEE N/A
  • NXL N/A
  • EPS
  • LEE N/A
  • NXL N/A
  • Revenue
  • LEE $581,809,000.00
  • NXL $174,813.00
  • Revenue This Year
  • LEE N/A
  • NXL $38.28
  • Revenue Next Year
  • LEE N/A
  • NXL $185.71
  • P/E Ratio
  • LEE N/A
  • NXL N/A
  • Revenue Growth
  • LEE N/A
  • NXL 16.42
  • 52 Week Low
  • LEE $3.79
  • NXL $0.70
  • 52 Week High
  • LEE $19.37
  • NXL $4.49
  • Technical
  • Relative Strength Index (RSI)
  • LEE 40.61
  • NXL 57.71
  • Support Level
  • LEE $4.40
  • NXL $1.44
  • Resistance Level
  • LEE $4.97
  • NXL $1.65
  • Average True Range (ATR)
  • LEE 0.35
  • NXL 0.15
  • MACD
  • LEE 0.01
  • NXL -0.01
  • Stochastic Oscillator
  • LEE 35.09
  • NXL 55.81

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: